Sato M, Terashima M, Takagane A, Saito K
Dept. of Surgery I, School of Medicine, Iwate Medical University.
Gan To Kagaku Ryoho. 1990 Aug;17(8 Pt 2):1793-8.
Arterial infusion therapy was applied to 92 patients with 40 unresectable, 30 non-curatively resected and 22 recurrent gastric cancers. 5-Fluorouracil (5-FU) was administered by arterial continuous infusion, Adriamycin (ADM) and mitomycin C (MMC) were given by bolus infusion in the hospital, and continuous arterial 5-FU infusion and ADM low-dose intermittent bolus infusion chemotherapy (AF therapy) were used for outpatients at home. The clinical effectiveness was evaluated. One-year cumulative survival rate of primary case by Kaplan-Meier method was 21.6%, and that of recurrent gastric cancer was 4.5%. In primary cases, the arterial infusion therapy was more effective in non-curatively resected cases than in unresectable ones. Total periods of infusion for outpatients were longer in efficacious cases. A long-surviving autopsy case was reported. AF therapy was considered an effective supportive treatment without any serious side effects for unresectable, non-curatively resected and recurrent gastric cancer, especially responders.
对92例患者实施了动脉灌注治疗,其中包括40例无法切除、30例非根治性切除和22例复发性胃癌患者。5-氟尿嘧啶(5-FU)采用动脉持续灌注给药,阿霉素(ADM)和丝裂霉素C(MMC)在医院采用大剂量推注给药,门诊患者在家中采用动脉持续5-FU灌注和ADM低剂量间歇推注化疗(AF疗法)。评估了临床疗效。采用Kaplan-Meier法计算,原发性病例的1年累积生存率为21.6%,复发性胃癌为4.5%。在原发性病例中,动脉灌注治疗在非根治性切除病例中比在无法切除的病例中更有效。有效病例中门诊患者的总灌注时间更长。报告了1例长期存活的尸检病例。AF疗法被认为是一种有效的支持性治疗方法,对无法切除、非根治性切除和复发性胃癌,尤其是有反应者,无任何严重副作用。